AzurRx BioPharma, Inc.·4

Apr 29, 8:22 PM ET

Riddell Alastair 4

4 · AzurRx BioPharma, Inc. · Filed Apr 29, 2019

Insider Transaction Report

Form 4
Period: 2019-03-31
Transactions
  • Award

    Common Stock

    2019-03-31$2.42/sh+7,500$18,15077,500 total
Footnotes (1)
  • [F1]Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2019.

Documents

1 file
  • 4
    form4-04292019_050458.xmlPrimary